ARTICLE | Clinical News
DSCO Phase IIa cystic fibrosis data
March 28, 2000 8:00 AM UTC
Discovery Laboratories said preliminary evaluation of its Phase II trial of SuperVent Aerosol tyloxapol anti-oxidant solution in cystic fibrosis patients showed a significant decrease in sputum interl...